The Family Medicine Channel

Bevacizumab Has Promise for Patients with Recurrent Cervical Cancer

1:00 | Family Medicine, Hospitalist, Internal Medicine, Ob/Gyn, Oncology, Oncology / Hematology, Pharmacists, Preventative Health, Surgery, Women’s Health

Results of a Gynecologic Oncology Group study suggest that for patients with recurrent cervical cancer, bevacizumab has demonstrated activity and promise as an option for second or third line therapy.

References and Resources
Gynecologic Oncology Group

More in Family Medicine

► 2:21:57

Virtual Conference: ISEH Adolescent Sports Medicine

Family Medicine

At the ISEH Adolescent Sports Medicine virtual conference, the speakers discussed common upper and lower limb problems, concussion management, and respiratory and breathing concerns in adolescents. Additional topics included managing...

► 1:04:07

The Reliability and Transferability of Current Randomized Controlled Trials Based on Real-World Evidence

Dermatology

Robert Kirsner, MD, PhD, University of Miami, Florida; Oscar M. Alvarez, PhD, Rutgers New Jersey Medical School, Newark, New Jersey; Vickie R. Driver, DPM, MS, INOVA Health System, Alexandria, Virginia;...

►

Physician Burnout: Addressing the Rapid Increase

Business of Medicine

Todd Unger, chief experience officer, AMA, and Christine Sinsky, MD, the AMA's vice president of professional satisfaction, discuss a recent study on physician burnout. Dr Sinsky explained that physician burnout...

► 58:01

Street Medicine: Why, What, How

Family Medicine

For the inaugural Macaran A. Baird, MD, Lecture in Family Medicine and Community Health Leadership, Jehni Robinson, MD, chair and clinical professor of the Department of Family Medicine and associate...